Recognising that some organisations may require additional time to complete implementation, the TGA has introduced a streamlined UDI Consent to Supply process commencing on 1 July 2026.
Early technical decisions shape long-term capability more than most teams initially recognise. Choices about methods, materials, tools, and architectures often become embedded constraints that are difficult to reverse later.
GMP does not begin at a single identifiable moment. It begins as soon as controlled processes and regulated decision-making become necessary to ensure product quality and patient safety.
Confidence, compliance, and commercial readiness represent three interdependent pillars of successful regulated product development and manufacturing.